A single-chain antibody against LMBV and its application in preparation of quantum dot fluorescent immunochromatographic test strip
The fluorescent immunochromatography technology that combines anti-LMBV single-chain antibodies with fluorescent quantum dot markers solves the problems of low sensitivity, weak specificity and complex operation of LMBV detection in existing technologies, and achieves rapid, efficient and economical virus detection, which is suitable for on-site detection of largemouth bass iridovirus.
Patent Information
- Application Number
- CN202411457247.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-18
- Publication Date
- 2025-10-17
- Estimated Expiration
- 2044-10-18
AI Technical Summary
Existing technologies for largemouth bass iridovirus (LMBV) detection have problems such as low sensitivity, weak specificity, complex operation, high cost, and unsuitability for rapid detection. Especially in aquaculture environments, it is difficult to meet the needs of fast, efficient, and accurate detection.
The fluorescent immunochromatography technology uses anti-LMBV single-chain antibody combined with fluorescent quantum dot markers to recognize and bind to the virus through highly specific antibodies, and uses fluorescent quantum dot-labeled antibodies to improve the sensitivity and accuracy of detection and simplify the operation steps.
It achieves rapid, efficient, economical and highly specific detection of LMBV, simplifies the operation process, and is suitable for on-site application, especially in providing rapid decision-making support in customs quarantine and sudden epidemic monitoring.